Indian Drugmaker Taps Private Credit for Japanese Acquisition
Indian pharmaceutical company Gujarat Themis Biosyn Ltd. secured private credit funding to acquire Japanese firm MicroBiopharm Japan Co., marking a trend of using private debt for Asian expansion.
Indian drugmaker Gujarat Themis Biosyn Ltd. has obtained private credit funding to back its purchase of Japanese peer MicroBiopharm Japan Co., highlighting the growing use of such debt for overseas expansion in Asia.
READ NEXT
More on the wire
AI TLDR
OpenAI is hosting its annual DevDay on September 29th in San Francisco. The company is expected to announce over 20 new launches during the keynote event.
AI TLDR
The recent summit between President Trump and Xi Jinping is being viewed as a strategic win for China. Details regarding the private discussions remain unclear.
AI TLDR
Expert Angelo Magliocca has released his predictions and betting picks for the 2026 MLB World Series.